✦ LIBER ✦
1462 POSTER A multicenter phase II trial of gefitinib 500 mg/day in 192 patients with advanced epidermal growth factor receptor-positive solid tumors who had failed previous chemotherapy
- Book ID
- 121996811
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 139 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.